Life Science Company News

Reset
Results 201 - 220 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  reMYND NV

Evelo Biosciences to Report Third Quarter 2021 Financial Results on Thursday, October 28, 2021

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  Evelo Biosciences, Inc.

Matinas BioPharma Initiates Dosing in Phase 1 Study of Potential First Oral Aminoglycoside Antibiotic Drug MAT2501

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  Matinas BioPharma Holdings Inc.

The Joint Corp. to Host Conference Call on Thursday, November 4th to Discuss Third Quarter 2021 Results

Read more ››
By: GlobenewsWire - 21 Oct 2021

PDS Biotech Provides Update on National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  PDS Biotechnology Corporation

BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial Ischemia

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  BioCardia, Inc.

First Wave BioPharma Forms Steering Committee for Phase 2a PASSPORT Clinical Trial to Evaluate FW-ICI-AC in Cancer Patients with Immune Checkpoint Inhibitor-Associated Colitis

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  First Wave BioPharma, Inc.

Jushi Holdings Inc. Secures US$100 Million Acquisition Facility from Sunstream

Read more ››
By: GlobenewsWire - 21 Oct 2021

Abeona Therapeutics to Present at Jefferies Gene Therapy/Editing Summit

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  Abeona Therapeutics, Inc.

OpGen Subsidiary Ares Genetics Launches AREScloud

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  OpGen, Inc.

Arbutus to Report Third Quarter 2021 Financial Results and Provide Corporate Update

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  Arbutus Biopharma Corporation

Intellia Therapeutics Receives U.S. FDA Orphan Drug Designation for NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  Intellia Therapeutics, Inc.

Nephros Announces Third Quarter 2021 Financial Results Conference Call

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  Nephros, Inc.

Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  Small Pharma Inc.

BioDelivery Sciences Appoints John Golubieski as Chief Financial Officer

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  BioDelivery Sciences International, Inc.

Adagene to Participate in the Jefferies Virtual China Biotech Summit

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  Adagene (Suzhou) Limited

VYNE Therapeutics Announces Formation of Scientific Advisory Board

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  VYNE Therapeutics Inc.

Cocrystal Pharma to Present Data from its Oral and Intranasal COVID-19 Therapeutics Programs at the World Antiviral Congress 2021

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  Cocrystal Pharma, Inc.

Calithera Biosciences to Present First Clinical Data from Development Program for Arginase Inhibitor CB-280 at NACFC 2021

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  Calithera Biosciences, Inc.

Zogenix to Release Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 4

Read more ››
By: GlobenewsWire - 21 Oct 2021
Related companies:  Zogenix Inc.
Results 201 - 220 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Click to get started »